London: American scientists have made significant progress in the treatment of malaria. Scientists at Oxford University say that the vaccine has an experimental effectiveness of up to 77%.
According to a foreign news agency, Oxford University experts used this new malaria vaccine R21 / Matrix-M vaccine on 450 children in the West African country of Burkina Faso, which showed amazing results. And the region has seen a significant reduction in the number of diseases caused by mosquito bites, which kill millions of children each year.
“In the final phase of the experiment, we will vaccinate 4,800 children in African countries in three and a half years,” said Adria Hill, head of the team that invented the vaccine, which was part of the Code-19 AstraZeneca team. He said that the experimental results of this vaccine have been excellent and better than expected. Because according to the World Health Organization, the vaccine’s effectiveness should be 75% and for the first time we have given results that are higher than the standards set by the WHO.
Malaria affects millions of people each year and kills more than 400,000 people, most of them infants and older children from poorer parts of Africa. Scientists around the world have been working for decades to develop the most effective vaccine against malaria, and so far only the GSK vaccine Mosquirix has been licensed after many years of clinical trials, but the effect of this vaccine Acceptability is up to 30%.